195 related articles for article (PubMed ID: 18030510)
1. Cost of care of colorectal cancers according to health care patterns and stage at diagnosis in France.
Clerc L; Jooste V; Lejeune C; Schmitt B; Arveux P; Quantin C; Faivre J; Bouvier AM
Eur J Health Econ; 2008 Nov; 9(4):361-7. PubMed ID: 18030510
[TBL] [Abstract][Full Text] [Related]
2. [Cost of colorectal cancer in France in 1999].
Selke B; Durand I; Marissal JP; Chevalier D; Lebrun T
Gastroenterol Clin Biol; 2003 Jan; 27(1):22-7. PubMed ID: 12594362
[TBL] [Abstract][Full Text] [Related]
3. Cost of diagnostic and therapeutic management of colorectal cancer according to stage at diagnosis in the Calvados Département, France.
Bouvier V; Reaud JM; Gignoux M; Launoy G
Eur J Health Econ; 2003; 4(2):102-6. PubMed ID: 15609176
[TBL] [Abstract][Full Text] [Related]
4. Cost of pretherapeutic staging of patients with colorectal cancer metastases in a French population.
Lejeune C; Logé P; Arveux P; Velten M; Jolly D; Woronoff-Lemsi MC; Guillemin F
Clin Res Hepatol Gastroenterol; 2011 May; 35(5):399-407. PubMed ID: 21317060
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of first-line chemotherapies in metastatic colorectal cancer. Results of the Fédération Francophone de Cancérologie Digestive (FFCD) 9601 randomized trial.
Borget I; Aupérin A; Pignon JP; Abbas M; Bouché O; Mousseau M; Raoul JL; Bedenne L; Cassan P; Clavero-Fabri MC; Stremsdoerfer N; Nasca S; Queuniet AM; Ducreux M;
Oncology; 2006; 71(1-2):40-8. PubMed ID: 17344670
[TBL] [Abstract][Full Text] [Related]
6. [Estimated cost of managing invasive cervical cancer in Tunisia].
Ben Gobrane H; Aounallah-Skhiri H; Oueslati F; Frikha H; Achour N; Hsairi M
Sante Publique; 2009; 21(6):561-9. PubMed ID: 20429226
[TBL] [Abstract][Full Text] [Related]
7. Cancer of the colorectum in Maine, 1995-1998: determinants of stage at diagnosis in a rural state.
Parsons MA; Askland KD
J Rural Health; 2007; 23(1):25-32. PubMed ID: 17300475
[TBL] [Abstract][Full Text] [Related]
8. Hospital health care resource utilization and costs of colorectal cancer during the first 3-year period following diagnosis in Switzerland.
Delcò F; Egger R; Bauerfeind P; Beglinger C
Aliment Pharmacol Ther; 2005 Mar; 21(5):615-22. PubMed ID: 15740546
[TBL] [Abstract][Full Text] [Related]
9. [Cost-effectiveness evaluation of predictive molecular diagnostics using the example of hereditary non-polyposis colorectal cancer (HNPCC)].
Hagen A; Hessabi HK; Gorenoi V; Schönermark MP
Gesundheitswesen; 2008 Jan; 70(1):18-27. PubMed ID: 18273760
[TBL] [Abstract][Full Text] [Related]
10. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
[TBL] [Abstract][Full Text] [Related]
11. Colonoscopy surveillance in asymptomatic subjects with increased risk for colorectal cancer: clinical evaluation and cost analysis of an Italian experience.
Matarese VG; Feo CV; Pezzoli A; Trevisani L; Brancaleoni M; Gullini S
Eur J Cancer Prev; 2007 Aug; 16(4):292-7. PubMed ID: 17554201
[TBL] [Abstract][Full Text] [Related]
12. Lifetime costs of colon and rectal cancer management in Canada.
Maroun J; Ng E; Berthelot JM; Le Petit C; Dahrouge S; Flanagan WM; Walker H; Evans WK
Chronic Dis Can; 2003; 24(4):91-101. PubMed ID: 14733758
[TBL] [Abstract][Full Text] [Related]
13. Trends in frequency and management of obstructing colorectal cancers in a well-defined population.
Cheynel N; Cortet M; Lepage C; Benoit L; Faivre J; Bouvier AM
Dis Colon Rectum; 2007 Oct; 50(10):1568-75. PubMed ID: 17687610
[TBL] [Abstract][Full Text] [Related]
14. [Surgical health care patterns and cancer cost: two studies using population registry data].
Schraub S; Arveux P; Mercier M; Gauthier M
Rev Epidemiol Sante Publique; 1996; 44 Suppl 1():S33-9. PubMed ID: 8935862
[TBL] [Abstract][Full Text] [Related]
15. Lifetime cancer-attributable cost of care for long term survivors of colorectal cancer.
Ramsey SD; Berry K; Etzioni R
Am J Gastroenterol; 2002 Feb; 97(2):440-5. PubMed ID: 11866285
[TBL] [Abstract][Full Text] [Related]
16. Cost of care for elderly cancer patients in the United States.
Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
[TBL] [Abstract][Full Text] [Related]
17. [Economic aspects of oncologic surgery: what do we know, are they relevant; must--may--we regard them?].
Nagel E; Meyer zu Vilsendorf A; Obermann K
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():91-7. PubMed ID: 9102021
[TBL] [Abstract][Full Text] [Related]
18. The incremental cost effectiveness of in-patient versus out-patient rehabilitation after total hip arthroplasty - results of a pilot investigation.
Krummenauer F; Günther KP; Witzlebf WC
Eur J Med Res; 2008 Jun; 13(6):267-74. PubMed ID: 18558552
[TBL] [Abstract][Full Text] [Related]
19. The economic impact of false-positive cancer screens.
Lafata JE; Simpkins J; Lamerato L; Poisson L; Divine G; Johnson CC
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2126-32. PubMed ID: 15598770
[TBL] [Abstract][Full Text] [Related]
20. Treatment costs of prostate cancer in the first year after diagnosis: a short-term cost of illness study for France, Germany, Italy, Spain and the UK.
Fourcade RO; Benedict A; Black LK; Stokes ME; Alcaraz A; Castro R
BJU Int; 2010 Jan; 105(1):49-56. PubMed ID: 20132102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
